Refametinib, 10 mg

Refametinib, 10 mg

Refametinib (selective MEK1/2 inhibitor) supplied by STEMCELL Technologies. Employed in preclinical research to block MAPK/ERK signaling in oncology and cell biology applications. Supplied as a 10 mg solid for preparation of concentrated stocks (commonly dissolved in DMSO); follow manufacturer storage and handling guidance. For research use only; not for clinical or human use.